PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
BIT:PHN - Euronext Milan - IT0005274094 - Common Stock - Currency: EUR
Overall PHN gets a fundamental rating of 7 out of 10. We evaluated PHN against 12 industry peers in the Personal Care Products industry. PHN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PHN is not valued too expensively and it also shows a decent growth rate. These ratings would make PHN suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year PHN was profitable.
PHN had a positive operating cash flow in the past year.
PHN had positive earnings in each of the past 5 years.
Each year in the past 5 years PHN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of PHN (20.02%) is better than 100.00% of its industry peers.
The Return On Equity of PHN (37.82%) is better than 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 24.62%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PHN is above the industry average of 12.78%.
The 3 year average ROIC (17.21%) for PHN is below the current ROIC(24.62%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.02% | ||
| ROE | 37.82% | ||
| ROIC | 24.62% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
PHN has a Profit Margin of 14.11%. This is in the better half of the industry: PHN outperforms 75.00% of its industry peers.
In the last couple of years the Profit Margin of PHN has declined.
PHN has a Operating Margin of 23.04%. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
PHN's Operating Margin has been stable in the last couple of years.
PHN has a better Gross Margin (94.85%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of PHN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.04% | ||
| PM (TTM) | 14.11% | ||
| GM | 94.85% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHN is creating value.
PHN has about the same amout of shares outstanding than it did 1 year ago.
PHN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for PHN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.87 indicates that PHN is not in any danger for bankruptcy at the moment.
The Altman-Z score of PHN (8.87) is better than 100.00% of its industry peers.
PHN has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
PHN has a Debt to FCF ratio (1.49) which is in line with its industry peers.
PHN has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PHN (0.32) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | 8.87 |
ROIC/WACC2.99
WACC8.24%
2.3 Liquidity
PHN has a Current Ratio of 2.38. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
PHN has a Current ratio of 2.38. This is amongst the best in the industry. PHN outperforms 91.67% of its industry peers.
A Quick Ratio of 2.12 indicates that PHN has no problem at all paying its short term obligations.
PHN has a Quick ratio of 2.12. This is amongst the best in the industry. PHN outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.38 | ||
| Quick Ratio | 2.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 13.49% over the past year.
The Earnings Per Share has been growing by 14.63% on average over the past years. This is quite good.
The Revenue has grown by 14.43% in the past year. This is quite good.
Measured over the past years, PHN shows a quite strong growth in Revenue. The Revenue has been growing by 16.59% on average per year.
EPS 1Y (TTM)13.49%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%37.79%
Revenue 1Y (TTM)14.43%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%99.35%
3.2 Future
PHN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.90% yearly.
Based on estimates for the next years, PHN will show a quite strong growth in Revenue. The Revenue will grow by 11.78% on average per year.
EPS Next Y16.46%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue Next Year14.39%
Revenue Next 2Y13.19%
Revenue Next 3Y11.78%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
PHN is valuated rather expensively with a Price/Earnings ratio of 20.24.
PHN's Price/Earnings is on the same level as the industry average.
PHN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.91.
Based on the Price/Forward Earnings ratio of 22.39, the valuation of PHN can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PHN is on the same level as its industry peers.
PHN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.77, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.24 | ||
| Fwd PE | 22.39 |
4.2 Price Multiples
PHN's Enterprise Value to EBITDA is on the same level as the industry average.
PHN's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.55 | ||
| EV/EBITDA | 10.9 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHN has an outstanding profitability rating, which may justify a higher PE ratio.
PHN's earnings are expected to grow with 12.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.23
PEG (5Y)1.38
EPS Next 2Y15.44%
EPS Next 3Y12.9%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.93%, PHN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.52, PHN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, PHN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.93% |
5.2 History
The dividend of PHN is nicely growing with an annual growth rate of 11.21%!
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
34.76% of the earnings are spent on dividend by PHN. This is a low number and sustainable payout ratio.
PHN's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP34.76%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
BIT:PHN (5/23/2025, 7:00:00 PM)
49.6
-0.6 (-1.2%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners15.09%
Inst Owner ChangeN/A
Ins Owners65%
Ins Owner ChangeN/A
Market Cap480.13M
Analysts82.86
Price Target84.66 (70.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.93% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP34.76%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.24 | ||
| Fwd PE | 22.39 | ||
| P/S | 2.88 | ||
| P/FCF | 29.55 | ||
| P/OCF | 23.42 | ||
| P/B | 7.72 | ||
| P/tB | 12.36 | ||
| EV/EBITDA | 10.9 |
EPS(TTM)2.45
EY4.94%
EPS(NY)2.22
Fwd EY4.47%
FCF(TTM)1.68
FCFY3.38%
OCF(TTM)2.12
OCFY4.27%
SpS17.21
BVpS6.42
TBVpS4.01
PEG (NY)1.23
PEG (5Y)1.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.02% | ||
| ROE | 37.82% | ||
| ROCE | 42.6% | ||
| ROIC | 24.62% | ||
| ROICexc | 36.28% | ||
| ROICexgc | 58.47% | ||
| OM | 23.04% | ||
| PM (TTM) | 14.11% | ||
| GM | 94.85% | ||
| FCFM | 9.75% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexcg growth 3Y-15.98%
ROICexcg growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score7
Asset Turnover1.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.47 | ||
| Cap/Depr | 108.2% | ||
| Cap/Sales | 2.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.44% | ||
| Profit Quality | 69.11% | ||
| Current Ratio | 2.38 | ||
| Quick Ratio | 2.12 | ||
| Altman-Z | 8.87 |
F-Score7
WACC8.24%
ROIC/WACC2.99
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.49%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%37.79%
EPS Next Y16.46%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue 1Y (TTM)14.43%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%99.35%
Revenue Next Year14.39%
Revenue Next 2Y13.19%
Revenue Next 3Y11.78%
Revenue Next 5YN/A
EBIT growth 1Y12.51%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year24.88%
EBIT Next 3Y16.72%
EBIT Next 5Y9.17%
FCF growth 1Y1504.49%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y69.54%
OCF growth 3Y0.14%
OCF growth 5Y11.34%